These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 769679)

  • 1. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of cephalosporins.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1976 Feb; 29(2):181-6. PubMed ID: 6411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
    Braveny I; Dickert H; Machka K
    Infection; 1979; 7(5):231-6. PubMed ID: 389804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
    Shah PM; Zwischenbrugger H; Stille W
    MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1973 Jun; 3(6):657-61. PubMed ID: 4790616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E; Marone P; Verani D; Marino P
    Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefatrizine activity compared with that of other cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1979 Feb; 15(2):209-12. PubMed ID: 426514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cephalothin on growth patterns of micro-organisms.
    Bodey GP; Pan T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1092-5. PubMed ID: 792494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.
    Knothe H; Shah P; Krcmery V; Antal M; Mitsuhashi S
    Infection; 1983; 11(6):315-7. PubMed ID: 6321357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of BL-S217, a new cephalosporin antibiotic.
    Casey F; Bodey GP
    J Antibiot (Tokyo); 1974 Jul; 27(7):520-4. PubMed ID: 4156357
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro susceptibility of selected bacteria to cefaclor.
    Valenti AJ; Andriole VT
    Yale J Biol Med; 1977; 50(5):465-9. PubMed ID: 341537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
    Verbist L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.